Skip to content

Fundus Oculi and Erectile Dysfunction

Evaluation of Vascularization of the Fundus Oculi in Patients With Erectile Dysfunction as Barometer of Patient's Health

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02845765
Enrollment
60
Registered
2016-07-27
Start date
2016-02-29
Completion date
2020-12-31
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Keywords

Erectile Dysfunction, ED, Fundus Oculi, Retinal Vascularization, International Index of Erectile Function Questionnaire, IIEF, Dynamic Vessel Analyzer, DVA, Phosphodiesterase type 5 Inhibitor, PDE5Is

Brief summary

The purpose of this study is to evaluate the correlation between fundus oculi's vascularization in patients with erectile dysfunction and not, and, in the same patients, before and after using drugs for ED.

Detailed description

The purpose of this study is to evaluate the correlation between fundus oculi's vascularization in patients with erectile dysfunction and not, and, in the same patients, before and after using drugs for ED. In this monocentric, prospective, observational case-control study 40 eyes of 40 patients affected by erectile dysfunction and 20 healthy age-matched controls will be enrolled. Patients will undergo DVA examination at baseline and 6 months after PDE5I therapy. Healthy subjects will be examined with DVA at baseline only.

Interventions

DRUGPhosphodiesterase type 5 Inhibitor (PDE5I)

Sponsors

Ospedale San Raffaele
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects with erectile dysfunction diagnosis (organic and psychogenic); * Subjects with Erectile Dysfunction diagnosis defined by IIEF score ≤ 25 * Subjects with stable partner for at least 6 months and sexually active. * Subjects aged between 40 - 60 years; * Signature of informed consent for patients

Exclusion criteria

* Subjects with ED secondary diagnosis to hormonal alterations (i.e. hypogonadism, hypo / hyperthyroidism, hyperprolactinemia); * Subjects with a diagnosis of ED post-traumatic and iatrogenic, since after pelvic surgery; * Subjects suffering from any ocular pathology that involves use of contact lenses and / or glasses; * Subjects smoking; * Individuals with uncontrolled systemic diseases; * All persons who do not confirm at least one criterion for inclusion.

Design outcomes

Primary

MeasureTime frameDescription
Static and dynamic retinal vessels diameterBaseline and after 6 month of therapyAnalysis of the presence and prevalence of retinal vascularization alterations using Dynamic Vessel Analyzer (DVA) in patients with Erectile Dysfunction and in subject healthy volunteers.

Secondary

MeasureTime frameDescription
International Index of Erectile Function (IIEF) QuestionnaireAfter 6 month of therapyRevaluation of the correlation between Erectile Dysfunction and Fundus Oculi vascularization after 6 month of therapy for ED.

Countries

Italy

Contacts

Primary ContactGiuseppe Querques, MD, PhD
giuseppe.querques@hotmail.it+39 0226434004
Backup ContactRoberta Scano
scano.roberta@hsr.it+39 0226435506

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026